Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-016498
Filing Date
2022-08-10
Accepted
2022-08-10 16:31:43
Documents
76
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vera-20220630.htm   iXBRL 10-Q 3005054
2 EX-31.1 vera-ex31_1.htm EX-31.1 19317
3 EX-31.2 vera-ex31_2.htm EX-31.2 19299
4 EX-32.1 vera-ex32_1.htm EX-32.1 12535
5 EX-32.2 vera-ex32_2.htm EX-32.2 12783
  Complete submission text file 0000950170-22-016498.txt   9496639

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vera-20220630_def.xml EX-101.DEF 282086
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vera-20220630_lab.xml EX-101.LAB 515475
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vera-20220630.xsd EX-101.SCH 68923
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vera-20220630_pre.xml EX-101.PRE 389684
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vera-20220630_cal.xml EX-101.CAL 51308
70 EXTRACTED XBRL INSTANCE DOCUMENT vera-20220630_htm.xml XML 1472796
Mailing Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005
Business Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005 650-770-0077
Vera Therapeutics, Inc. (Filer) CIK: 0001831828 (see all company filings)

EIN.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40407 | Film No.: 221152269
SIC: 2834 Pharmaceutical Preparations